A detailed history of Jones Financial Companies Lllp transactions in 10x Genomics, Inc. stock. As of the latest transaction made, Jones Financial Companies Lllp holds 1,044 shares of TXG stock, worth $14,939. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,044
Previous 127 722.05%
Holding current value
$14,939
Previous $2,000 1050.0%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$15.71 - $23.49 $14,406 - $21,540
917 Added 722.05%
1,044 $23,000
Q2 2024

Aug 14, 2024

BUY
$19.45 - $37.37 $2,470 - $4,745
127 New
127 $2,000

Others Institutions Holding TXG

About 10x Genomics, Inc.


  • Ticker TXG
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 95,046,400
  • Market Cap $1.36B
  • Description
  • 10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumabl...
More about TXG
Track This Portfolio

Track Jones Financial Companies Lllp Portfolio

Follow Jones Financial Companies Lllp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jones Financial Companies Lllp, based on Form 13F filings with the SEC.

News

Stay updated on Jones Financial Companies Lllp with notifications on news.